Navigation Links
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device

inties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors, including timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timing and acceptance of our new products scheduled for fiscal year 2009, and introduction of competitive products and other factors beyond our control, could result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2009. A more complete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you should consider each of those factors when evaluating the forward-looking statements.

ThermoGenesis Corp.

Web site:

Contact: Investor Relations

+1-916-858-5107, or

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
2. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
3. ThermoGenesis Names Tiffany Olson to Board of Directors
4. ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))
5. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
6. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
7. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
8. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
9. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
10. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
11. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
Post Your Comments:
(Date:10/1/2015)... WORCESTER, Mass. and TORONTO ... ( ) (OTCQB: GNBT) today announced the issuance ... for medicinal purposes and the joint venture between Generex ... design and development of products for the delivery of ... the buccal mucosa (the inner lining of the mouth). ...
(Date:10/1/2015)... 2015  xG Health Solutions, a leading healthcare ... new platform for communication and collaboration with healthcare ... and health plans improve the quality and efficiency ... solutions, products and educational resources. ... clinicians, we know the process of re-engineering care ...
(Date:10/1/2015)... 1, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug ... in the upcoming Aegis Growth Conference, taking place October ...  Josh Hexter, COO of Oramed, will present a corporate ... Details:   2015 Aegis Growth Conference ...
(Date:10/1/2015)... (PRWEB) , ... October 01, 2015 , ... Mark Seymour, of Radiant Hearth in Potsdam, ... and built a Tulikivi masonry heater for the Mac Kentley family in northern New York. ... that the family's boiler did. One fire is normally enough to keep the home comfortable ...
Breaking Biology Technology:Generex Announces Issuance of Buccal Cannabis White Paper 2Generex Announces Issuance of Buccal Cannabis White Paper 3Generex Announces Issuance of Buccal Cannabis White Paper 4xG Health Solutions Launches New Platform for Hospitals, Clinics and Health Plans 2Oramed to Present at the Aegis Capital Growth Conference 2Oramed to Present at the Aegis Capital Growth Conference 3The Masonry Heater Association of North America Receives News About A New York Couple Who Saved Considerable Money Heating Their Home With A Wood Fired Masonry Heater 2
... 15 Congressional Quarterly presents a 360-degree look at ... versions of biotech drugs. This CQ Forum will include ... and leading researchers regarding the complex structures of biologics ... the availability of these products save money for consumers? ...
... Pharmaceuticals, Inc. (Nasdaq: HEPH ), a leader in ... based on endogenous adrenal steroid hormones, today announced the board ... and CEO of Hollis-Eden Pharmaceuticals, Inc. Dr. Frincke was ... , Dr. Frincke joined Hollis-Eden as Vice President, Research and ...
... , HONOLULU, June 15 Nanopoint Inc., an ... products, today announced that effective immediately its cellTRAY ... to the European marketplace. Nanopoint,s cellTRAY Imaging and ... of applications including drug discovery, assisted reproductive technology ...
Cached Biology Technology:Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO 2Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO 3Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems 2
(Date:9/28/2015)... 28, 2015 The global ... USD 12.03 billion by 2020, growing at a CAGR ... as Backside Illumination (BSI) technique to improve picture quality ... period.      (Logo: , ... to reduce loss and, thus, reduce the noise interference ...
(Date:9/26/2015)... 26th, 2015  Results of a TactioRPM pilot ... today at the Stanford Medicine X Conference. In ... Dashboards, Connected Health Devices and Pharmacogenomics", Roger ... will explain how senior patients equipped with connected ... pharmacist via the TactioRPM remote patient monitoring platform ...
(Date:9/10/2015)... This report provides detailed descriptions of the sensor types ... types that will dominate in the future. Many product ... technology hype curve in the last five years before ... all of them is the prominence of sensor options ... Sensors collect data about the physical and chemical properties ...
Breaking Biology News(10 mins):Image Sensors Market Size to Reach $12.03 Billion By 2020: Grand View Research, Inc. 2Image Sensors Market Size to Reach $12.03 Billion By 2020: Grand View Research, Inc. 3Image Sensors Market Size to Reach $12.03 Billion By 2020: Grand View Research, Inc. 4Image Sensors Market Size to Reach $12.03 Billion By 2020: Grand View Research, Inc. 5Results of TactioRPM Pilot in a Senior Home Unveiled at Stanford Med X Conference 2Results of TactioRPM Pilot in a Senior Home Unveiled at Stanford Med X Conference 3Wearable Sensors 2015-2025: Market Forecasts, Technologies, Players 2
... limited by the seasons, particularly in colder climates ... researchers and fruit breeders, newly developed varieties are ... produce fruit during the offseasonresulting in economic bonuses ... the new varieties of blackberry called "primocane-fruiting", which ...
... The roe of hake, lumpsucker and salmon is the best dietary ... researchers at the University of Almera (UAL). The scientists analysed the ... these contained high levels of these fatty acids, which are essential ... precise understanding of the nutritional potential of the roe of marine ...
... , SAN DIEGO, ... has converted part of an existing building (Keen Hall), including ... cell core facility for the University of California, Riverside. ... , "A key project element was to ensure that although ...
Cached Biology News:New management methods extend blackberry season 2Roe of marine animals is best natural source of omega-3 2Kornberg Associates | Architects Completes UC Riverside Stem Cell Core Facility Project 2